Preliminary in vitro approach to evaluate the drug-drug interaction potential of EST73502, a dual µ-opioid receptor partial agonist and σ1 receptor antagonist-Reference-Cited by-同舟云学术

Preliminary in vitro approach to evaluate the drug-drug interaction potential of EST73502, a dual µ-opioid receptor partial agonist and σ1 receptor antagonist

Published:2021-02-23 Issue:5 Volume:51 Page:501-512
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Ayet Eva¹,Yeste Sandra¹,Reinoso Raquel F.¹,Pretel María José²,Balada Ariadna²,Serafini Maria Teresa¹

Affiliation:

1. WELAB, Parc Científic Barcelona, Baldiri Reixac 4-8, Barcelona 08028, Spain

2. Early ADME, Drug Discovery and Preclinical Development, ESTEVE Pharmaceuticals S.A, Barcelona, Spain

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2021.1877850

Reference45 articles.

1. Current industrial practices of assessing permeability and P-glycoprotein interaction

2. THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE

3. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment

4. Sigma antagonists potentiate opioid analgesia in rats

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Emerging Role of Sigma Receptors in Pain Medicine;Cureus;2023-07-28

2. Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids;Acta Pharmaceutica Sinica B;2023-01